mitomycin has been researched along with Ascites in 33 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Ascites: Accumulation or retention of free fluid within the peritoneal cavity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Activated carbon particles adsorbing mitomycin C (MMC-CH) was administered to four patients with peritoneal carcinomatosis of gastric cancer into their abdominal cavities." | 7.72 | [Intraperitoneal chemotherapy against peritoneal carcinomatosis of gastric cancer with activated carbon particles adsorbing mitomycin C for four patients]. ( Chou, H; Fujita, Y; Hagiwara, A; Kawakami, S; Ohgaki, M; Shiomi, A; Takashina, K; Takenaka, A; Yamagishi, H, 2004) |
| "The amounts of mitomycin C (MMC) taken up into rat ascites hepatoma cells were determined by measuring the decrease in the absorbance of the incubation medium at 363 nm." | 7.67 | Enhancement of mitomycin C uptake by isoproterenol in rat ascites hepatoma. ( Koshiura, R; Matsunaga, T; Miyamoto, K; Waki, Y, 1986) |
| "Mitomycin C was administered as a perfusate at 10 mg/l." | 5.32 | Treatment of peritoneal carcinomatosis in patients with digestive cancers with combination of intraperitoneal hyperthermia and mitomycin C. ( Banssillon, V; Bienvenu, J; Francois, Y; Garbit, F; Gilly, FN; Glehen, O; Grandclément, E; Panteix, G; Sadeghi-Looyeh, B; Sayag-Beaujard, AC; Vignal, J, 2004) |
| "Four patients suffering from malignant ascites were treated with the following method: peritoneal lavage and consequent injection of Mitomycin-C (20 mg/body surface m2) was performed for six hours via a catheter put into the peritoneal cavity according to Seldinger's method." | 4.78 | [First experiences with intraperitoneal chemotherapy]. ( Pikó, B; Vadon, G, 1991) |
| "Activated carbon particles adsorbing mitomycin C (MMC-CH) was administered to four patients with peritoneal carcinomatosis of gastric cancer into their abdominal cavities." | 3.72 | [Intraperitoneal chemotherapy against peritoneal carcinomatosis of gastric cancer with activated carbon particles adsorbing mitomycin C for four patients]. ( Chou, H; Fujita, Y; Hagiwara, A; Kawakami, S; Ohgaki, M; Shiomi, A; Takashina, K; Takenaka, A; Yamagishi, H, 2004) |
| "35 ovarian cancer patients with ascites have been treated intraperitoneally with mitomycin C or mitoxantrone or interferon beta or tumor necrosis factor (TNF)." | 3.68 | [Locoregional ascites therapy with cytostatic drugs and immune modulators in gynecologic neoplasms]. ( Chronides, A; Diedrich, K; Krebs, D; Mallmann, P; Wagner, U; Werner, A, 1991) |
| "The amounts of mitomycin C (MMC) taken up into rat ascites hepatoma cells were determined by measuring the decrease in the absorbance of the incubation medium at 363 nm." | 3.67 | Enhancement of mitomycin C uptake by isoproterenol in rat ascites hepatoma. ( Koshiura, R; Matsunaga, T; Miyamoto, K; Waki, Y, 1986) |
| "Pseudomyxoma peritonei is a disease that results from a perforated mucinous neoplasm of the appendix so that mucinous ascites and mucin-producing tumor cells are widely disseminated in a characteristic pattern throughout the abdomen and pelvis." | 1.46 | Management of an inguinal hernia in patients with pseudomyxoma peritonei. ( Sugarbaker, PH, 2017) |
| "Ascites was from gastric cancer (5 cases), colorectal cancer (3 cases), ovarian cancer (3 cases), breast cancer (2 cases) and peritoneal mesothelioma (1 case)." | 1.33 | Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. ( Garcia, J; Garofalo, A; Sugarbaker, PH; Valle, M, 2006) |
| "Treatment of advanced gastric cancers with peritonitis carcinomatosa is very difficult, because none of the various therapies (operation, chemotherapy, hyperthermia etc." | 1.32 | [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites]. ( Doi, K; Horiuchi, T; Nakamura, T; Okubo, Y; Shimada, K; Tanabe, S; Tanaka, K; Tanaka, S; Uchinami, M; Yoshida, M, 2004) |
| "Mitomycin C was administered as a perfusate at 10 mg/l." | 1.32 | Treatment of peritoneal carcinomatosis in patients with digestive cancers with combination of intraperitoneal hyperthermia and mitomycin C. ( Banssillon, V; Bienvenu, J; Francois, Y; Garbit, F; Gilly, FN; Glehen, O; Grandclément, E; Panteix, G; Sadeghi-Looyeh, B; Sayag-Beaujard, AC; Vignal, J, 2004) |
| "Diffuse pyogenic gelatinous ascites and a large cystic mass with a grayish wall, and a hard solid lesion in part were found." | 1.31 | Disseminated peritoneal adenomucinosis associated with a panperitonitis-like onset: report of a case. ( Kuroki, Y; Otagiri, S; Tsukada, K, 2001) |
| "We report 42 cases of gastric cancer with peritoneal carcinosis treated with intraperitoneal chemohyperthermia." | 1.30 | [Intraperitoneal chemo-hyperthermia with mitomycin C in cancer of the stomach with peritoneal carcinosis]. ( Bienvenu, J; François, Y; Garbit, F; Gilly, FN; Glehen, O; Grandclément, E; Peyrat, PP; Sadeghi-Looyeh, B; Sayag-Beaujard, AC; Vignal, J, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (48.48) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 7 (21.21) | 29.6817 |
| 2010's | 5 (15.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ong, E | 1 |
| Diven, C | 1 |
| Abrams, A | 1 |
| Lee, E | 1 |
| Mahadevan, D | 1 |
| Bespalov, VG | 1 |
| Vyshinskaya, EA | 1 |
| Vasil'eva, IN | 1 |
| Semenov, AL | 1 |
| Maidin, MA | 1 |
| Barakova, NV | 1 |
| Stukov, AN | 1 |
| Sugarbaker, PH | 2 |
| Cui, S | 1 |
| Ba, M | 1 |
| Tang, Y | 1 |
| Liu, J | 1 |
| Wu, Y | 1 |
| Wang, B | 1 |
| Zhang, X | 1 |
| Tang, H | 1 |
| Zhong, S | 1 |
| Benizri, EI | 1 |
| Bereder, JM | 1 |
| Rahili, A | 1 |
| Bernard, JL | 1 |
| Benchimol, D | 1 |
| KERSTEN, H | 1 |
| THEMANN, H | 1 |
| IWATA, S | 1 |
| KAGEYAMA, T | 1 |
| HANO, S | 1 |
| ISHII, H | 1 |
| WAKABAYASHI, A | 1 |
| WADA, M | 1 |
| KURISU, T | 1 |
| FUJII, M | 1 |
| TSUTSUMI, T | 1 |
| TARNOWSKI, G | 1 |
| KULKA, P | 1 |
| BATES, L | 1 |
| SAFIER, S | 1 |
| SATTERWHITE, H | 1 |
| SOLNEY, E | 1 |
| UENO, K | 1 |
| MATSUYAMA, M | 1 |
| SUZUMORI, K | 1 |
| NAKAMURA, T | 2 |
| KOIZUMI, A | 2 |
| YOSHIDA, K | 1 |
| TAKAHASHI, T | 1 |
| YAMAGUCHI, I | 1 |
| MAJIMA, S | 1 |
| HATTORI, T | 1 |
| ENDO, S | 1 |
| HAGIHARA, K | 1 |
| HIRONO, I | 1 |
| KOJIMA, K | 1 |
| KACHI, H | 1 |
| OHASHI, A | 1 |
| SASAOKA, I | 1 |
| NIITANI, H | 1 |
| SUZUKI, A | 1 |
| SHIMOYAMA, M | 1 |
| KIMURA, K | 1 |
| Shimada, K | 1 |
| Okubo, Y | 1 |
| Tanaka, S | 1 |
| Tanabe, S | 1 |
| Yoshida, M | 1 |
| Doi, K | 1 |
| Uchinami, M | 1 |
| Horiuchi, T | 1 |
| Tanaka, K | 2 |
| Ohgaki, M | 1 |
| Takenaka, A | 1 |
| Shiomi, A | 1 |
| Chou, H | 1 |
| Takashina, K | 1 |
| Kawakami, S | 1 |
| Fujita, Y | 1 |
| Hagiwara, A | 1 |
| Yamagishi, H | 1 |
| Sayag-Beaujard, AC | 2 |
| Francois, Y | 2 |
| Glehen, O | 2 |
| Sadeghi-Looyeh, B | 2 |
| Bienvenu, J | 2 |
| Panteix, G | 1 |
| Garbit, F | 2 |
| Grandclément, E | 2 |
| Banssillon, V | 1 |
| Vignal, J | 2 |
| Gilly, FN | 2 |
| Mizuta, Y | 1 |
| Akazawa, Y | 1 |
| Shiozawa, K | 1 |
| Ohara, H | 1 |
| Ohba, K | 1 |
| Ohnita, K | 1 |
| Isomoto, H | 1 |
| Takeshima, F | 1 |
| Omagari, K | 1 |
| Yasutake, T | 1 |
| Nakagoe, T | 1 |
| Shirono, K | 1 |
| Kohno, S | 1 |
| Garofalo, A | 1 |
| Valle, M | 1 |
| Garcia, J | 1 |
| Ogura, T | 1 |
| Shinzato, O | 1 |
| Sakatani, M | 1 |
| Shindo, H | 1 |
| Namba, M | 1 |
| Kishimoto, S | 1 |
| Yamamura, Y | 1 |
| Feng, H | 1 |
| Yamazaki, M | 1 |
| Matsuki, N | 1 |
| Saito, H | 1 |
| Loggie, BW | 1 |
| Perini, M | 1 |
| Fleming, RA | 1 |
| Russell, GB | 1 |
| Geisinger, K | 1 |
| Peyrat, PP | 1 |
| Ben-Ari, G | 1 |
| Scott, D | 1 |
| Zippel, D | 1 |
| Sareli, M | 1 |
| Koller, M | 1 |
| Papa, M | 1 |
| Kuroki, Y | 1 |
| Otagiri, S | 1 |
| Tsukada, K | 1 |
| Werner, A | 1 |
| Mallmann, P | 1 |
| Chronides, A | 1 |
| Diedrich, K | 1 |
| Wagner, U | 1 |
| Krebs, D | 1 |
| Pikó, B | 1 |
| Vadon, G | 1 |
| Miyamoto, K | 1 |
| Matsunaga, T | 1 |
| Waki, Y | 1 |
| Koshiura, R | 1 |
| Maeda, H | 1 |
| Matsumura, Y | 1 |
| Molla, A | 1 |
| Yamashita, S | 1 |
| Ito, T | 1 |
| Kinashi, N | 1 |
| Yakabe, A | 1 |
| Athlin, L | 1 |
| Domellöf, L | 1 |
2 reviews available for mitomycin and Ascites
| Article | Year |
|---|---|
Pseudomyxoma peritonei accompanied by intraductal papillary mucinous neoplasm of the pancreas.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; | 2005 |
[First experiences with intraperitoneal chemotherapy].
Topics: Abdominal Neoplasms; Antineoplastic Agents; Ascites; Follow-Up Studies; Humans; Injections, Intraper | 1991 |
2 trials available for mitomycin and Ascites
| Article | Year |
|---|---|
B ultrasound-guided hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Chemotherapy, Cancer, Regional Perfus | 2012 |
Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy.
Topics: Antibiotics, Antineoplastic; Ascites; Combined Modality Therapy; Female; Gastrointestinal Neoplasms; | 1997 |
29 other studies available for mitomycin and Ascites
| Article | Year |
|---|---|
Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for palliative treatment of malignant ascites from gastrointestinal stromal tumours.
Topics: Aged; Antibiotics, Antineoplastic; Ascites; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tum | 2012 |
Comparative Study of Antitumor Efficiency of Intraperitoneal and Intravenous Cytostatics in Experimental Rats with Disseminated Ovarian Cancer.
Topics: Adenocarcinoma, Papillary; Animals; Antineoplastic Agents; Ascites; Cisplatin; Female; Injections, I | 2017 |
Management of an inguinal hernia in patients with pseudomyxoma peritonei.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal N | 2017 |
Ascites and malnutrition are predictive factors for incomplete cytoreductive surgery for peritoneal carcinomatosis from gastric cancer.
Topics: Antibiotics, Antineoplastic; Ascites; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Hype | 2013 |
[Morphological and biochemical changes in ascites tumor cells in mice following administration of mitomycin C].
Topics: Animals; Ascites; Carcinoma; Carcinoma, Ehrlich Tumor; DNA; DNA, Neoplasm; Mice; Mitomycin; Mitomyci | 1962 |
[CLINICAL AND EXPERIMENTAL STUDIES ON CHANGES IN THE BODY FLUIDS IN CANCER].
Topics: Antineoplastic Agents; Arginine; Ascites; Aspartate Aminotransferases; Blood Chemical Analysis; Bloo | 1963 |
EFFECTS OF CHEMICAL TREATMENT IN VITRO OF NELSON MOUSE ASCITES TUMOR CELLS ON THEIR TRANSPLANTABILITY AND ON SOME INDICES OF GLUCOSE METABOLISM.
Topics: Animals; Antineoplastic Agents; Ascites; Aziridines; Carbohydrate Metabolism; Carbon Isotopes; Carbo | 1963 |
[EXPERIMENTAL STUDIES ON THE PREVENTION OF HEMATOGENIC METASTASIS OF CANCER WITH ANTICANCER DRUGS].
Topics: Ascites; Blood Circulation; Injections, Intravenous; Liver Neoplasms; Mitomycin; Mitomycins; Neoplas | 1964 |
INDUCTION OF HYDRONEPHROSIS BY PROLONGED INTRAPERITONEAL INJECTIONS OF SUB-TOXIC DOSE OF MITOMYCIN C IN MICE.
Topics: Ascites; Body Weight; Hydronephrosis; Hydrothorax; Injections, Intraperitoneal; Kidney; Liver; Lung; | 1964 |
INHIBITORY EFFECT OF ANTI-CANCER CHEMOTHERAPEUTICS ON LIVER METASTASIS OF INTRAPORTALLY INOCULATED MOUSE ASCITES HEPATOMA.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Ascites; Carcinoma, Hepatocellular; Injection | 1964 |
CYTOCIDAL EFFECTS OF MITOMYCIN-C ON MH-134 ASCITES TUMOR CELLS IN VITRO.
Topics: Animals; Ascites; Carcinoma, Ehrlich Tumor; In Vitro Techniques; Mice; Mitomycin; Mitomycins; Neopla | 1964 |
THE USE OF RAT ASCITES TUMORS HETEROGRAFTED IN MICE FOR SCREENING OF ANTICANCEROUS AGENTS.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Ascites; Carcinoma, Ehrlich Tumor; Carcinoma, | 1963 |
[EXPERIMENTAL STUDIES ON THE EFFECT OF ANTI-CANCER CHEMOTHERAPEUTICS TO LIVER METASTASIS FOLLOWING PORTAL INJECTION OF MOUSE ASCITES HEPATOMA].
Topics: Animals; Ascites; Carcinoma, Hepatocellular; Liver Neoplasms; Lung Neoplasms; Mice; Mitomycin; Mitom | 1963 |
[DEVELOPMENT OF FREE-CELL SUBLINES OF THE ASCITES HEPATOMA AH-130 AND THEIR BIOLOGICAL PROPERTIES].
Topics: Ascites; Carcinoma, Hepatocellular; Chromosomes; Electrons; Liver Neoplasms; Mechlorethamine; Micros | 1964 |
[EFFECT OF MITOMYCIN-C INJECTION ON LYSOSOMAL ENZYMIC ACTIVITIES OF YOSHIDA ASCITES SARCOMA].
Topics: Acid Phosphatase; Animals; Ascites; Deoxyribonucleases; DNA; Histocytochemistry; Lysosomes; Mitomyci | 1964 |
[A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Drug Administrati | 2004 |
[Intraperitoneal chemotherapy against peritoneal carcinomatosis of gastric cancer with activated carbon particles adsorbing mitomycin C for four patients].
Topics: Adsorption; Aged; Antibiotics, Antineoplastic; Ascites; Biomarkers, Tumor; Charcoal; Dosage Forms; F | 2004 |
Treatment of peritoneal carcinomatosis in patients with digestive cancers with combination of intraperitoneal hyperthermia and mitomycin C.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Ascites; Carcinoma; Combined Modality Therapy; Female; Gas | 2004 |
Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cisplatin; Doxorubicin; Female; Human | 2006 |
Analysis of therapeutic effect in experimental chemoimmunotherapy for rat ascites tumor.
Topics: Adjuvants, Immunologic; Animals; Ascites; Cell Line; Fibrosarcoma; Male; Mitomycin; Mitomycins; Noca | 1982 |
Anti-tumor effects of orally administered soft-shelled turtle powder in mice.
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Ascites; Liver Ne | 1996 |
[Intraperitoneal chemo-hyperthermia with mitomycin C in cancer of the stomach with peritoneal carcinosis].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Ascites; Carcinoma; Cause of Death; Chemotherapy, Cancer, | 1997 |
Continuous hyperthermic peritoneal perfusion (CHPP) for malignant ascites and irresectable intra-abdominal cancer.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cell Division; Cisplat | 2000 |
Disseminated peritoneal adenomucinosis associated with a panperitonitis-like onset: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Cisplatin; Combined Modality Therapy; Diagn | 2001 |
[Locoregional ascites therapy with cytostatic drugs and immune modulators in gynecologic neoplasms].
Topics: Ascites; Breast Neoplasms; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Interferon- | 1991 |
Enhancement of mitomycin C uptake by isoproterenol in rat ascites hepatoma.
Topics: Animals; Ascites; Bucladesine; Cell Line; Cell Survival; Cells, Cultured; Cyclic AMP; Dose-Response | 1986 |
Antitumor activity of some bacterial proteases: eradication of solid tumors in mice by intratumor injection.
Topics: Animals; Ascites; Mice; Mitomycin; Mitomycins; Neoplasms, Experimental; Peptide Hydrolases; Protease | 1987 |
[Clinical study of intraperitoneal chemotherapeutic perfusion (IPCP) of mitomycin C (MMC) and intraperitoneal administration of cisplatin].
Topics: Ascites; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Drug Therapy, Combination; Evaluation | 1987 |
Effects of fluorouracil, doxorubicin and FAM combination on human peritoneal macrophages.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Ascites; | 1987 |